1/23
05:07 pm
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at
Weiss Ratings . They set a "sell (e)" rating on the stock.
Neutral
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at
Weiss Ratings . They set a "sell (e)" rating on the stock.
1/9
07:41 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
1/9
07:00 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
1/5
07:00 am
mplt
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Low
Report
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
12/20
01:30 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
12/16
07:00 am
mplt
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Medium
Report
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
12/4
07:00 am
mplt
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
High
Report
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
11/26
06:43 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: GILLIS JONATHAN
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: GILLIS JONATHAN
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Setia Vishwas
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Setia Vishwas
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Kreitzer Anatol
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Kreitzer Anatol
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Foff Erin Pennock
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Foff Erin Pennock
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Lillie James Woodruff
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Lillie James Woodruff
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Hanson Kristopher
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Hanson Kristopher
2/9
05:50 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Kroeger Christopher A.
Neutral
Report
Form 4 MapLight Therapeutics, For: Feb 05 Filed by: Kroeger Christopher A.
2/4
09:15 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 02 Filed by: Malenka Robert C.
Medium
Report
Form 4 MapLight Therapeutics, For: Feb 02 Filed by: Malenka Robert C.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register